Related by context. All words. (Click for frequent words.) 70 immunochemical 69 immunohistochemical 68 CIN2 + 68 T SPOT.TB 68 Cervista HPV HR 68 immunohistochemistry IHC 68 HER2 expression 67 miRview mets 67 microRNA profiling 66 miRview TM mets 66 guaiac 66 VeraTag 66 quantitative PCR 66 miRview ™ squamous 66 Immunohistochemical staining 66 abnormal cytology 66 Mass Spectrometry MS 65 p# biomarker 65 Histopathologic 65 NADiA 65 DNA methylation biomarkers 65 Epigenomics proprietary 65 Corus CAD 65 RT qPCR 65 immunohistochemical analysis 65 cytological 65 PET tracers 65 STRIDE PD 65 ELISpot 65 tumorigenicity 65 duplex ultrasonography 64 protein electrophoresis 64 eTag assays 64 Septin9 64 PCR assay 64 HAAH 64 NADiA ProsVue 64 CINtec ® PLUS 64 Quantitation 64 Alkaline Phosphatase 64 bisulfite sequencing 64 sDNA 64 multiplex PCR 64 immunohistochemical staining 64 RQ PCR 64 metastatic neuroendocrine tumors 64 Affymetrix microarray technology 64 anti JCV antibodies 64 viral tropism 64 miRview squamous 63 immunochemical fecal occult 63 immunoblotting 63 qRT PCR 63 Flow cytometry 63 immunofluorescent 63 genomic biomarker 63 prostate carcinoma 63 ELISPOT 63 Annexin V 63 PCA3 63 intraobserver 63 assay detects 63 PNA FISH TM 63 metabolite identification 63 splice variants 63 ELISA assays 63 MammaPrint R 63 multiplexed assays 63 DHPLC 63 squamous intraepithelial lesions 63 epithelial tumors 63 Squamous 63 comparative genomic hybridization 63 vitro assay 63 proteomic biomarkers 63 bronchial lavage 63 Genotypic 63 genomewide 63 BRAF V#E mutation 63 VerifyNow P#Y# 63 genotypic 63 CCX# 63 KRAS mutation 63 gastric adenocarcinoma 63 multiplex assay 63 PCA3 gene 63 serologic 62 ASCUS 62 sensitivity specificity 62 FDG PET imaging 62 Neisseria gonorrhoeae 62 mSEPT9 62 IDI MRSA 62 gene expression assays 62 cervical cytology 62 immunostaining 62 antitumor effect 62 Tr DNA 62 K ras mutations 62 mutated K ras 62 Hemoccult II 62 Western blotting 62 serum biomarkers 62 urothelial carcinoma 62 co receptor tropism 62 multicentric 62 urine dipstick 62 Affymetrix GeneChip 62 microRNA biomarkers 62 Cytogenetic 62 index assay IVDMIA 62 immunoblot 62 LungAlert TM 62 PGxPredict 62 RRM1 62 IL#B 62 pharmacodynamic markers 62 TPMT 62 Mammostrat 62 clinico pathological 62 Immunohistochemistry 62 fosbretabulin 62 molecular diagnostic assay 62 NMP# 62 DNA methylation biomarker 62 nested PCR 62 TMPRSS2 ERG 62 prognostic biomarker 62 methylation markers 62 HERmark 62 assay ELISA 62 bronchoalveolar lavage 62 molecular determinants 62 GSTP1 62 HER2 overexpression 62 NSCLC tumors 62 SELDI TOF MS 62 methylated DNA 62 pharmacokinetic PK 62 genotypic resistance 62 AtherOx 62 PreGen Plus 62 molecular diagnostic assays 62 molecular assays 62 diagnostic biomarker 62 amaZon 62 vivo potency 62 HIFU therapy 62 Mutation Detection 62 multi analyte 62 perfusion imaging 62 Septin 9 62 Epidermal Growth Factor Receptor 62 VeriStrat 61 thymidylate synthase TS 61 FDG-PET/CT 61 Illumina GoldenGate 61 miRview meso 61 reagent kit 61 non nucleoside 61 Her2/neu 61 multigene expression test 61 CINtec R 61 hc2 61 HER2 ErbB2 61 endoglin 61 prospectively defined 61 Serological 61 Antigen CEA 61 careHPV 61 prostate cancer PCa 61 ProFlu + 61 carcinoembryonic antigen 61 thyroglobulin 61 ADAMTS# 61 Xanafide 61 enzyme immunoassay 61 ELISA enzyme 61 micrometastasis 61 Cervista HPV 61 Reproducibility 61 Lp PLA 2 61 #T# L1 61 AGHD 61 viral kinetics 61 miRview ™ mets 61 serological tests 61 qNPA 61 MAGE A3 61 independent prognostic marker 61 gastric carcinoma 61 HBsAg 61 #F FDG PET 61 #S rDNA 61 CYT# potent vascular disrupting 61 UGT#A# 61 K RAS 61 lactate dehydrogenase LDH 61 interobserver reliability 61 Immunohistochemistry IHC 61 Activity Assay 61 hENT1 61 metastatic lymph nodes 61 oncologic outcomes 61 miRNA profiling 61 SiMoA 61 quantitative RT PCR 61 ChIP chip 61 TaqMan 61 CA9 SCAN 61 qualitative serum 61 Microarray analysis 61 LNA TM 61 Solorel TM 61 miRNA biomarkers 61 ImmuKnow 61 SAXS 61 PITX2 61 pain palliation 61 prospective multicentre 61 prognostic markers 61 HC2 test 61 prognostic indicators 61 metabolomic profiles 61 cell lysate 61 replicon 61 LC-MS/MS 61 Anticalins ® 61 scintigraphic 61 EUS FNA 61 sestamibi 61 cTnT 61 Viatronix V3D Colon 61 MVA BN R 61 massively parallel sequencing 61 Western Blotting 61 interobserver 61 MALDI-TOF/TOF 61 HER2 gene 61 prognostic marker 61 peptide conjugated 60 ResponseDX Colon TM 60 immunofluorescence staining 60 A3 adenosine receptor 60 reagent kits 60 HPV genotyping 60 TMPRSS2 ERG fusion 60 ABCB1 60 aCGH 60 flavopiridol 60 pelvic ultrasound 60 pharmacodynamic PD 60 MAGE A3 ASCI 60 Abbott ARCHITECT 60 convergent validity 60 RT PCR assay 60 plasma pharmacokinetics 60 Immunohistochemical 60 CellSearch ™ 60 Cystatin C 60 microarray gene expression 60 radiotherapeutic 60 PSA nadir 60 Meta analyzes 60 Locked Nucleic Acid LNA 60 PCR RFLP 60 Digene HPV Test 60 Taqman 60 nodal metastasis 60 colorectal adenoma 60 indirect immunofluorescence 60 Abbott RealTime 60 PCWP 60 malignant nodules 60 HGPIN 60 PSMA ADC 60 cleavable linker 60 quantitative PCR qPCR 60 ImmuKnow R 60 D Dimer 60 breast carcinoma 60 Cardiac Allograft Rejection 60 HTRF R 60 accurate quantitation 60 histopathologic 60 bone scintigraphy 60 BACcel ™ system 60 Immunohistochemical analysis 60 tumor specific antigen 60 F FDG PET 60 hemagglutination inhibition HAI 60 Oncotype DX colon cancer 60 cardiac troponin T 60 mass spectrometric 60 Septin9 biomarker 60 BRIM3 60 CC genotype 60 BRIM2 60 MedPulser 60 radiation dosimetry 60 nucleic acid assays 60 acid phosphatase PAP 60 electrophysiologic 60 promoter methylation 60 PCR Polymerase Chain Reaction 60 MTT assay 60 Breast Cancer Assay 60 antinuclear antibody 60 microRNA expression 60 urine cytology 60 transfection efficiency 60 NMR LipoProfile test 60 #S rRNA gene 60 Rosetta Genomics microRNA 60 automated immunoassay 60 HERmark assay 60 trastuzumab emtansine T DM1 60 ResponseDX Lung TM 60 TaqMan R 60 PCa 60 Histologic 60 Immunotherapeutic 60 florbetaben 60 NADiA R 60 microbiologically evaluable 60 xCELLigence System 60 ColonSentry ™ 60 cMET 60 PDGF receptor 60 transcriptome sequencing 60 reaction RT PCR 60 chemosensitivity 60 trastuzumab DM1 T DM1 60 anti CD3 60 protein quantitation 60 EGFR TKIs 60 ToGA 60 differentially expressed genes 60 HCV replicon 60 Non inferiority 60 T#I [002] 60 colorectal carcinomas 60 urodynamic 60 kidney urologic 60 microsatellite instability 60 enzyme immunoassay EIA 60 Alfacell proprietary ribonuclease 60 NGAL 60 flow cytometric 60 molecular biomarkers 60 Radient Pharmaceutical current 60 ceftazidime 60 cTnI 60 microdose 60 MarginProbe 60 metabolite concentrations 60 interobserver agreement 60 Aplidin 60 KIF6 gene 60 Haptoglobin 60 tumor hypoxia 60 transabdominal 60 Fine needle aspiration 60 Clusterin 60 biomarker identification 60 Roche AmpliChip 60 intact parathyroid hormone 60 PCA3 assay 60 PD2i ® 60 specific antigen PSA 60 cytolytic activity 60 PEGylated interferon 60 Tumor Response 60 variant allele 60 gene amplification 60 OnDose TM 60 FISH fluorescence 60 oligonucleotide ligation 60 Multimeric 60 GeneSearch BLN Assay 60 GAMMAGARD 60 Sanger sequencing 60 HLA DQ2 60 #F FDG 60 tumor biopsies 60 EDEMA3 trial 60 urothelial 60 cisplatin resistant 59 molecular biomarker 59 prostate cancer CaP 59 antiangiogenic agents 59 LHRH receptor positive 59 precursor lesions 59 metabolomic profiling 59 proteomic analysis 59 Azedra 59 novel VDA molecule 59 Hexvix 59 antibiotic susceptibility 59 BACcel 59 p# antigen 59 ELISA assay 59 SCIB1 59 COLD PCR 59 multiplex assays 59 virulence genes 59 transcriptomic 59 KRAS mutation status 59 spectrophotometric 59 VerifyNow 59 clevidipine 59 Amplicor 59 obstructive coronary artery 59 HER-2/neu 59 paraffin embedded tissue 59 Alferon LDO 59 DNAWitness Y 59 cytologic 59 D dimer 59 miRview ® 59 mutational analysis 59 immunocytochemistry 59 Trofex 59 TaqMan ® 59 pre malignant lesions 59 Prospective Randomized 59 histological subtype 59 transcriptional profiling 59 Pharmacodynamic 59 QPCR 59 prospective multicenter study 59 pharmacodynamic properties 59 situ hybridization 59 targeted radiotherapeutic 59 methylenetetrahydrofolate reductase 59 Myocardial Perfusion Imaging 59 lactate dehydrogenase 59 VITAL Trial 59 Oncotype DX breast cancer 59 IgG antibody 59 papillary renal cell carcinoma 59 KRAS status 59 atherothrombotic disease 59 IntroductionThe 59 SNP rs# [001] 59 viral nucleic acids 59 RECAF TM 59 assay kits 59 C Reactive Protein 59 differentiate squamous 59 Anticalins R 59 diagnostic modality 59 retrospective cohort 59 xCELLigence 59 myelofibrosis polycythemia vera 59 biomolecular interactions 59 BCR ABL mutations 59 etiologic 59 PCR amplified 59 LungExpress Dx 59 Vasogen Celacade 59 bFGF 59 TPI ASM8 59 SPINK1 59 DNA methylation markers 59 Onalta TM 59 Infinium assay 59 tumor histology 59 pancreatic prostate 59 albumin excretion rate 59 sonographically guided 59 biodistribution 59 MassARRAY platform 59 HLA genotyping 59 genomic profiling 59 sPLA2 59 delafloxacin 59 EpCAM 59 Ophena 59 Azedra ™ 59 enzyme linked immunosorbent 59 Prostate Specific Antigen PSA 59 CYP#D# gene 59 diagnostic biomarkers 59 Endometrial 59 advanced adenomas 59 OvaRex MAb 59 thyroid carcinoma 59 NanoChip R 59 endocrine therapies 59 multiparametric 59 VEGF expression 59 quantitative gene expression 59 presymptomatic 59 radezolid 59 K#N 59 percutaneous biopsy 59 ABL1 59 untreated metastatic melanoma 59 grade squamous intraepithelial 59 prognostic significance 59 BEXXAR Therapeutic Regimen 59 prognostic indicator 59 heparanase 59 HIV1 59 xMAP technology 59 cobas HPV Test 59 DiLA2 Platform 59 solithromycin 59 antibody titer 59 anti JCV antibody 59 microdeletions 59 mertansine 59 TriGrid 59 FDG uptake 59 colon capsule endoscopy 59 situ hybridisation 59 leiomyomas 59 OVA1 ® 59 gene rearrangements 59 Xelox 59 Epi proColon 59 putative biomarkers 59 TT genotype 59 Curaxin 59 Hybrid Capture 59 genomic biomarkers 59 myeloperoxidase 59 dose proportionality 59 predictive biomarker 59 phenotypic expression 59 P2V TM 59 deCODE AF TM 59 Histological 59 HNSCC 59 pathophysiological effects 59 DNAWitness Mito 59 array CGH 59 quantitative cytology 59 immunoassay kits 59 YONDELIS 59 reaction PCR 59 Detect Ready MRSA 59 multicenter Phase II 59 troponin assay 59 immunomodulation 59 FDG PET scans 59 LC MALDI 59 OnDose 59 HER2 positive cancers 58 KineMarker TM 58 GFT# 58 CCR5 inhibitor 58 EasyCD4 58 antimicrobial susceptibility testing 58 Oncotype DX ® 58 EP #R 58 mammographic density 58 neratinib 58 Onalta ™ 58 Aspergillus nidulans 58 Protein Expression 58 Chlamydia trachomatis infection 58 reverse transcriptase polymerase chain 58 tropism testing 58 Comparative Genomic Hybridization 58 genotoxicity 58 siRNA knockdown 58 NimbleGen arrays 58 miRNA expression 58 VKORC1 58 Silodosin 58 haematological 58 NRTI resistance 58 colonoscopic 58 genetic biomarkers 58 myocardial necrosis 58 Kit v2 58 SensoLyte ™ 58 EGFR HER 58 effector function 58 inflammatory biomarkers 58 myelodysplastic myeloproliferative diseases 58 Prostate specific antigen 58 menstrual stem cell 58 Pertuzumab 58 positron emission 58 Anticalin ® 58 chromosome #p# [002] 58 humanised antibody 58 Radical prostatectomy 58 NPM1 mutation 58 Src inhibitors 58 maternal serum 58 peptide antigens 58 PROSTASCINT R 58 APTIMA 58 CISH 58 DGGE 58 Seeplex 58 FlexmiR 58 mucinous 58 TCF#L# 58 EndoTAG TM 58 PhenoSense GT 58 Diabetes Risk Score 58 Onalta 58 Nucleic Acid Detection Immunoassay 58 AxSYM 58 neoplasias 58 Peptidomics 58 evaluating tivozanib 58 optical biosensors 58 NB S# strontium malonate 58 pharmacogenetic 58 immunoglobulin G 58 ovarian endometrial 58 Analyte 58 TLE3 58 CTAP# Capsules 58 gene expression microarrays 58 Onko Sure ® 58 ALN TTR# 58 NNRTI resistance 58 diagnostic prognostic 58 clade B 58 RNA amplification 58 PIK3CA 58 spirometric 58 Prostate Lung Colorectal 58 haematologic 58 preclinical efficacy 58 chlamydial infection 58 Hexvix ® 58 FLT3 58 TIMP 1 58 EGFR HER2 58 depsipeptide 58 CEQ# 58 WT1 58 Tasigna prolongs 58 relapsed MM 58 Estrogen Receptor 58 Gram stain 58 lupus anticoagulant 58 uricase 58 EGFR tyrosine kinase inhibitors 58 thorough QT 58 immunofluorescence 58 enzyme inhibition 58 riociguat 58 CBLC# 58 Upregulation 58 NOD mouse 58 LAB CGRP 58 HER2 neu 58 chlamydial 58 KRAS mutations 58 S. maltophilia 58 transthoracic 58 antibody MAb 58 transient elastography 58 cytotoxicity assays 58 cagA 58 differentially expressed proteins 58 quantitative polymerase chain 58 K ras 58 PD2i R 58 tests miRview TM 58 ResponseDX Lung ™ 58 ERalpha 58 ImmuKnow TM 58 PreDx 58 Dx TM 58 adenomatous 58 VivaGel ™ 58 candidates Azedra TM 58 CINQUIL 58 Cervista 58 cytogenic 58 ALK mutations 58 Sanger Sequencing 58 DNA methyltransferases 58 core needle biopsies 58 liquid chromatography tandem 58 tryptase 58 ERBB2 58 Screening Trial 58 clinicopathological 58 gene rearrangement 58 Vizilite 58 ocular formulation 58 apolipoproteins 58 automated microscopy 58 spiral computed tomography 58 Vaxfectin R adjuvant 58 thyroid peroxidase 58 ALK inhibitors 58 biostatistical analysis 58 HER2 amplification 58 synthetic lethality 58 LEAPS TM 58 HemeScan 58 surgically resected 58 transrectal ultrasound 58 genotyping assay 58 surface plasmon resonance SPR 58 LightTouch 58 lymphatic mapping 58 hepatocellular carcinomas 58 Cathepsin B 58 HepG2 cells 58 #S rRNA 58 concurrent chemoradiation 58 tubulin inhibitor 58 mRNA transcripts 58 chromosomal mutations 58 gastric carcinomas 58 mitochondrial DNA mtDNA 58 IGF IR 58 Dynabeads 58 AlzheimAlert TM 58 induced sputum 58 Multivariate logistic regression 58 tumoral 58 phosphoprotein 58 prospectively stratified 58 LabChip Dx 58 CSF Tf 58 β1 58 Fludara ® 58 differential gene expression 58 N. gonorrhoeae 58 virosome 58 kinase profiling 58 epithelial ovarian cancer 58 MGd 58 XmAb# 58 MMP# 58 KRAS oncogene 58 BRAF mutation 58 esophageal carcinoma 58 multiplexing capability 58 Prostatic 58 Histopathological 58 AttoSense 58 BCIRG 58 GV# [001] 58 steroidogenic 58 Trofile assay 58 NicAlert 58 metastatic colorectal 58 GeneChip ® 58 Pharmacokinetic PK 58 amplified nucleic acid 58 cDNA microarray 58 sarcosine 58 ADVEXIN therapy 58 radiolabeling 58 serum biomarker 58 PC Detect SM 58 System IPSS 58 proton MR spectroscopy 58 reverse transcription polymerase 58 pCR 58 NADiA TM 58 AST ALT 58 Protein Kinase C 58 isotypes 58 Transcriptome 58 APTIMA HPV assay 58 cervical intraepithelial neoplasia 58 pituitary adenomas 58 Trichomonas vaginalis 58 VeraCode 58 ELISA kit 58 esophageal gastric 58 myocardial perfusion 58 quantitate 58 QTOF 58 chromatin immunoprecipitation ChIP 58 Oncotype 58 RhuDex ® 58 serogroup B 58 APTIMA R 58 biomarker assay 58 Dalbavancin 58 NicAlert TM 58 MammaPrint ® 58 MSMB 58 gastrointestinal stromal tumors GISTs 58 adenoviral 58 ENMD # 58 pathologic examination 58 troponin T 58 phenotyping 58 sorafenib tablets 58 endoscopic retrograde 58 quantitative reverse transcriptase 58 iroxanadine 58 RDTs 58 PSP# [002] 58 ovarian malignancy 58 histone deacetylase inhibitor 58 chimeric monoclonal antibody 58 Cardiotoxicity 58 vitro diagnostic multivariate 58 Infinium HD 58 antimitotic 58 tropism assay 58 protein tyrosine phosphatase 1B 58 HPV-#/# 58 microwell plate 58 UroVysion 58 UPLYSO 58 vitro molecular diagnostic 58 x ray angiography 58 cell lysates 58 fallopian tube cancers 58 Gastrointestinal Stromal Tumors 58 circulating endothelial cells 58 BRAF mutations 58 eNO 58 androgen dependent 58 deacetylase 58 semiquantitative 58 low expressors 58 insertional mutagenesis 58 ELACYT 58 WavSTAT 58 SNP rs# [002] 58 receptor tyrosine kinase inhibitor 58 MammaPrint 58 #q# deletion 58 cervical carcinoma 58 Ovarian PLCO Cancer 58 genes differentially expressed 58 hypermethylated 58 pharmacodynamic parameters 58 adeno associated viruses 58 Fc gamma receptor 58 miRs 58 HIF 1α 58 ovarian pancreatic 58 colorectal adenocarcinoma 58 vitro ADME 58 ^ Tc 57 Gag polymorphisms 57 aminotransferase 57 buffy coat 57 tissue microarrays 57 lung pancreatic 57 FullTerm 57 seropositivity 57 pharmacologic stress 57 Troponin T 57 interleukin IL -# 57 Outpatient Setting 57 rs# [001] 57 MVA BN ® 57 aurora kinase 57 OMP #M# 57 thymidine kinase 57 ultrasonographic examination 57 monoclonal antibody mAb 57 Daptomycin 57 SPECT CT imaging 57 urine albumin 57 HER2 HER3 57 SNP genotyping 57 E. faecalis 57 5 hmC 57 CDKN2A 57 Situ Hybridization 57 SELDI 57 DIGE 57 CE IVD 57 transcranial Doppler ultrasound 57 EGFR mutation status 57 LungCAD 57 transesophageal echocardiography 57 histological diagnosis 57 Quantitative PCR 57 siRNA transfection 57 CCR9 57 HRCT 57 ESBA# 57 transgene expression 57 designated HVTN 57 serum lipid levels 57 Solazed ™ 57 Septin 9 biomarker 57 quantitative proteomics 57 Afatinib 57 miRview TM squamous 57 tTG 57 diagnosing coronary artery 57 IGRAs 57 BACcel ™ 57 multivariate Cox 57 CHEK2 57 urography 57 inhibit EGFR 57 recurrent metastatic 57 serologic testing 57 vaginal lesions 57 lymph node metastasis 57 cardiac perfusion 57 erythropoietic 57 HCV genotyping 57 cystoscopic 57 Immunogenicity 57 therapeutic monoclonal antibody 57 Myeloperoxidase 57 liposomal amphotericin B 57 ChIP seq 57 Kahalalide F 57 ULTRIO 57 CyPath 57 somatic mutations 57 preoperative staging 57 histone deacetylase HDAC 57 RUO 57 breast cancer subtypes 57 PREVU * LT 57 nucleic acid amplification 57 Optical coherence tomography 57 preclinically 57 Pharmacokinetics PK 57 gene inactivation 57 Surface Plasmon Resonance 57 CellPort Technologies 57 deCODE BreastCancer 57 neurosensory 57 detect XMRV 57 MALDI TOF MS 57 QRT PCR 57 human IgG1 monoclonal 57 grade cervical intraepithelial 57 Vaxfectin TM 57 serological 57 lentiviral 57 FDG PET CT 57 Olerup SSP 57 GLP toxicology studies 57 Accelerated Partial Breast Irradiation 57 thyrotropin 57 pharmacokinetic PK study 57 tumor subtypes 57 specific IgE 57 INTERCEPT platelets 57 OvPlex 57 multicentre randomized 57 Detect Ready 57 VivaGel TM 57 biochemical assays 57 Screening Trial DMIST 57 histologic examination 57 Galectin 3 57 throughput RNAi 57 lymphadenectomy 57 Fetal Fibronectin Test 57 splice junctions 57 Hemopurifier TM 57 neutrophil gelatinase associated lipocalin 57 coexpression 57 PHPT 57 SmartChip System 57 RhuDex R 57 perfusion MRI 57 Ki# 57 radiolabeled TM# 57 hydroxy vitamin D 57 RNA seq 57 FGFR4 57 TLR antagonists 57 meganuclease 57 hSBA 57 AmpliChip 57 CyPath ® 57 micafungin 57 galiximab 57 virotherapy 57 pretargeting 57 B7 H3 57 biopsied tissue 57 Co Receptor Tropism 57 biomarker 57 nucleic acid sequence 57 ano genital warts 57 intradermal injection 57 experimentally validated 57 pelvic malignancies 57 alvespimycin 57 hepatic fibrosis 57 histopathologic findings 57 serous ovarian cancer 57 plasmid DNA vaccine 57 chest radiographs